Specifically, the plasma level of a potential protein marker, vitamin D binding protein (DBP), was measured using ELISA in another 60 HD patients to characterize the clinical significance of DBP during a 4-year prospective follow-up. This evidence concerns the gene DBP and Huntington disease.